New method to produce chemically modified mRNA developed

In a recent study, the research group at the University of Cologne's Institute of Organic Chemistry led by Professor Dr Stephanie Kath-Schorr describes a novel method for the enzymatic production of synthetic messenger RNA (mRNA). While natural base modifications of mRNA are already being used - for example by BioNTech/Pfizer for the production of their coronavirus vaccine - this newly developed mRNA additionally contains site-specifically introduced, non-natural nucleotides. Nucleotides are molecules that function as the basic building blocks of RNA. This new approach using non-natural nucleotides allows the scientists to study how mRNA is introduced into cells and to observe how the newly introduced information spreads at the cellular level. This in turn promises better therapeutic applications in the long run. The article 'Stronger together for in cell translation: natural and unnatural base modified mRNA' has appeared in Chemical Science . Previous methods did not allow for the production of mRNAs with chemically modified building blocks at specific positions because mRNAs are produced enzymatically due to their length of several thousands of building blocks.